Re-balancing an over- or under-active immune response.
Stem cells' ability to calm overactive immune responses—suppressing inflammation and promoting tolerance rather than triggering rejection. This is especially relevant for autoimmune, inflammatory bowel, and rheumatoid conditions. The mechanism is real and well-documented, but effect size varies widely; not all patients respond, and responses fade over time. When clinics claim immunomodulation, ask for patient-stratification data: which baseline immune profiles respond best? Single case reports are common; ask for cohort data with objective biomarkers (IL-6, TNF-α, regulatory T-cell counts) showing the immune shift persists beyond 3 months.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment